Effect of Stellate Ganglion Block on Meniere's Disease

• Status: Completed
• Trial end date: 2012-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Stellate ganglion block (SGB) has been the alternative treatment of Meniere's disease for years. However, objective evidence of the effect of SGB was still lack. The investigators conducted a randomized controlled study to examine the immediate effects of SGB in SP/AP of electrocochleography (ECoG).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chi Mei Medical Hospital
• Treatments: alpha-Tocopherol; Diphenidol; Niacin; Nicotinic Acids; Tocopherols; Tocotrienols; Vitamin E

Criteria

Inclusion Criteria:

• patients diagnosed with unilateral Meniere's disease, according to the criteria of the American Academy of Otolaryngology-Head and Neck Surgery, AAO-HNS (1995)

Exclusion Criteria:

• patients with coagulopathy,

• arrhythmia,

• myocardial ischemia,

• glaucoma,

• pregnant,

• chronic otitis media or externa, and

• past history of middle or inner ear surgery were excluded.